MalmstrÖm Susanna
R&D Project Manager and COCHEOFIX Project Director
research and the pharmaceutical
CILcare
France
Biography
Dr. Malmström has more than 12 years’ experience in academic research and in the preclinical pharmaceutic CRO-business. Before joining CILcare, she spent five years working with rodent models and biomarker validation in the area of neurodegenerative diseases. She is expert in managing research and development projects, with a broad in vitro- and in vivo technical competence. She coordinates and drives the pharmacokinetic studies at CILcare and as such, she interacts with international experts of the field, who she involves in the continuous improvement of CILcare’s protocols. In addition, she drives Cochleofix, one of CILcare’s key collaborative projects with KeenEye and the contribution of the Institut Pasteur. Susanna holds a Ph. D in biochemistry and molecular biology from the University of Lund, Sweden, in the field of ion transport. She obtained her M.A. from the University of Texas in Austin and conducted part of her thesis work in Copenhagen, Denmark. She is the author of several scientific publications. Aurore graduated with honors in Project Management and Innovation in Biotechnology from the University of Montpellier. Dr. Malmström has more than 12 years’ experience in academic research and in the preclinical pharmaceutic CRO-business. Before joining CILcare, she spent five years working with rodent models and biomarker validation in the area of neurodegenerative diseases. She is expert in managing research and development projects, with a broad in vitro- and in vivo technical competence. She coordinates and drives the pharmacokinetic studies at CILcare and as such, she interacts with international experts of the field, who she involves in the continuous improvement of CILcare’s protocols. In addition, she drives Cochleofix, one of CILcare’s key collaborative projects with KeenEye and the contribution of the Institut Pasteur. Susanna holds a Ph. D in biochemistry and molecular biology from the University of Lund, Sweden, in the field of ion transport. She obtained her M.A. from the University of Texas in Austin and conducted part of her thesis work in Copenhagen, Denmark. She is the author of several scientific publications. Aurore graduated with honors in Project Management and Innovation in Biotechnology from the University of Montpellier.
Research Interest
preclinical pharmaceutic
